linoserpaturev
Generic: CAN-3110·Code: CAN-3110
linoserpaturev: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Candel Therapeutics, Inc. (CADL) | Phase 1 |
Get deeper analysis on linoserpaturev
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis